Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis

NCT01863238 is registered in ClinicalTrials.gov with Vertex Pharmaceuticals Incorporated as lead sponsor.

NCT NCT01863238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01863238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Lead sponsor
Vertex Pharmaceuticals Incorporated
Phase
Observational
Overall status
Completed
Start date
May 31, 2013
Completion date
May 31, 2016
Enrollment
95 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis